Skip to content

Investigacion Farmaceutica S.A. DE C.V.

MexicoFDA applicant, unverified

Devices
24

What Investigacion Farmaceutica S.A. DE C.V. makes

The company manufactures in vitro diagnostic (IFA) tests for antibiotic susceptibility, including assays for bacitracin, penicillin, imipenem, cephalotin, tetracycline, streptomycin, nalidixic acid, gentamicin, norfloxacin, and polymyxin B, as well as diagnostic tests for *Proteus* OX-19 and *Brucella* antigens.

These products are regulated under FDA’s Class I and Class II device classifications, with some submissions recorded via the 510(k) pathway. The company’s diagnostics are listed in the FDA’s 510(k) registry, and the manufacturer is based in the United States.

AI-generated from registry data, 3 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue24

Newest first, rows 1-24 of 24

Search and filter all 24 devices
Skip device list
  • Ifa Sensibac Bacitracin Ref K892717

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • Ifa Sensibac Penicillin Ref K892726

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • Ifa Sensibac Inipenem Ref K892727

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • Ifa Sensibac Cephalotin Ref K892735

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • Ifa Sensibac Tetracycline Ref K892718

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • Ifa Sensibac Streptomycin Ref K892724

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • Proteus Ox-19 Ifa* Ref K885110

    Active Regimes: 510(k) Registry: 510(k) Class:I
  • Ifa Sensibac Nalidixic Acid Ref K892713

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • Ifa Sensibac Gentamycin Ref K892720

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • Ifa Sensibac Norfloxacin Ref K892728

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • Ifa Sensibac Polymyxin B Ref K892723

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • Brucella Ifa* Ref K885112

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • Ifa Sensibac Neomycin Ref K892714

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • Ifa Sensibac Vancomycin Ref K892725

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • Ifa Sensibac Nitrofurantoin Ref K892715

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • Ifa* Positive And Negative Antigens Control Ref K885113

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • Ifa Sensibac Cefaclor Ref K892721

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • Thrombostin Ifa* Ref K885107

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • Ifa Sensibac Cinoxacin Ref K892722

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • Ifa Sensibac Kanamycin Ref K892733

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • Ifa Sensibac Chlroamphenicol Ref K892730

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • Ifa Sensibac Tobramycin Ref K892729

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • Salmonella Ifa* Ref K885114

    Active Regimes: 510(k) Registry: 510(k) Class:I
  • Ifa Sensibac Erythromycin Ref K892719

    Active Regimes: 510(k) Registry: 510(k) Class:II

Rows 1-24 of 24

Frequently asked questions

How many devices does Investigacion Farmaceutica S.A. DE C.V. have in the registry?

The registry currently lists 24 devices for Investigacion Farmaceutica S.A. DE C.V.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Investigacion Farmaceutica S.A. DE C.V.'s devices?

Among its 24 most recently registered devices, Investigacion Farmaceutica S.A. DE C.V. has devices listed in FDA 510(k) (24 devices).

What risk classes do Investigacion Farmaceutica S.A. DE C.V.'s devices fall under?

Among its 24 most recently registered devices, the classes recorded for Investigacion Farmaceutica S.A. DE C.V.'s devices are Class I and Class II. Each device page shows its own class and authorisation.

What are the newest devices from Investigacion Farmaceutica S.A. DE C.V. in the registry?

The most recently registered devices listed for Investigacion Farmaceutica S.A. DE C.V. include IFA SENSIBAC BACITRACIN, IFA SENSIBAC PENICILLIN, IFA SENSIBAC INIPENEM and IFA SENSIBAC CEPHALOTIN.

Generated automatically from registry data and not verified by a human reviewer.